SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-015255
Filing Date
2021-03-25
Accepted
2021-03-25 06:37:45
Documents
4
Effectiveness Date
2021-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 inzy-s8.htm S-8 103362
2 EX-5.1 inzy-ex51_6.htm EX-5.1 16338
3 EX-23.1 inzy-ex231_7.htm EX-23.1 2579
4 GRAPHIC gcn2uytk4yjd000001.jpg GRAPHIC 13959
  Complete submission text file 0001564590-21-015255.txt   142749
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254685 | Film No.: 21770074
SIC: 2834 Pharmaceutical Preparations